My favorate stock :: essays research papers

Stock name ADVANCED NEUROMODULATION SYSTEMS INC.Stock attribute AISI.OSECTOR HealthcareINDUSTRY Medical Equipment & SuppliesOverviewAdvanced Neuromodulation Systems, Inc. (ANSI), designs, develops, manufactures and markets advanced implantable neuromodulation devices that repair the quality of life for people suffering from chronic chafe. Neuromodulation devices include implantable neurostimulation devices, which award electric current at present to targeted nerves, and implantable drug pumps, which deliver small, precisely controlled doses of drugs directly to targeted sites within the body.GROWTH RATES1 Year3 years5 Years gross sales %32.5747.1227.54EPS %33.80103.4515.06Dividend %NMNMNM tax incomeQuarters2001200220032004MAR8,34111,47319,67126,633JUN9,20513,42322,32430,488SEP9,90014,32823,41931,330DEC10,47018,14825,66832,293Totals37,91657,37291,082120,744Note Units in Thousands of U.S. Dollars meshing PER SHAREQuarters2001200220032004MAR0.0000.0530.1330.190JUN0.0270.0900.1400 .210SEP0.0330.1000.1900.230DEC0.0470.1270.1800.240Totals0.1070.3700.6430.870Note Units in U.S. DollarsQuick monetary Synopsis Advanced Neuromodulation Systems designs, develops, manufactures and markets implantable neuromodulation for chronic back pain or nervous system disorders. For the FY ended 12/31/04, receiptss rosaceous 33% to $120.7M. Net income rose 37% to $18.2M. Revenues reflect increased unit sales from Neuro Products and O.E.M. business segments. Net income also reflects increased operating bound as well as increased investment income.Actual revenue and EPS for the latest fiscal yearActual revenue $US 120.7 millions recent share price and date$US 27.23March 29, 2005Month of the federations fiscal year endDecemberIndicate one-year dividend per share0.00ValuationValuation RatiosRATIO COMPARISONValuation Ratios confederacyIndustrySectorS&P 500P/E Ratio (TTM)32.5433.5528.9721.43P/E High - Last 5 Yrs.NM60.5450.3042.31P/E Low - Last 5 Yrs.20.8822.6519.8815.75Price to S ales (TTM)4.894.945.212.87Price to Book (MRQ)2.555.534.993.92Price to Tangible Book (MRQ)3.0413.9411.837.15Price to currency Flow (TTM)23.5524.9321.9114.76Price to Free Cash Flow (TTM)367.7632.7230.1825.30% Owned Institutions95.0028.5647.2665.58DividendsDividends gildIndustrySectorS&P 500Dividend YieldNA0.792.172.12Dividend Yield - 5 Year Avg.0.000.451.041.58Dividend 5 Year step-up pass judgmentNM10.5411.379.06Payout Ratio (TTM)0.0015.0229.3829.26 gain RatesGrowth Rates (%) telephonerIndustrySectorS&P 500Sales (MRQ) vs. Qtr. 1 Yr. Ago25.8119.3315.0717.60Sales (TTM) vs TTM 1 Yr. Ago32.5722.6716.3315.81Sales - 5 Yr. Growth Rate27.5415.8816.019.76EPS (MRQ) vs Qtr. 1 Yr. Ago36.7213.870.4716.59EPS (TTM) vs TTM 1 Yr. Ago34.0124.509.6824.79EPS - 5 Yr. Growth Rate15.0627.2016.0113.64Capital Spending - 5 Yr. Growth Rate24.4213.3311.593.15Financial StrengthFinancial StrengthCompanyIndustrySectorS&P 500Quick Ratio (MRQ)15.841.991.941.20Current Ratio (MRQ)18.782.792.541.69LT Debt to fair pl ay (MRQ)0.000.380.370.63Total Debt to Equity (MRQ)0.000.440.440.79Interest Coverage (TTM)NM17.3810.8111.87 gainfulness RatiosProfitability Ratios (%)CompanyIndustrySectorS&P 500 crude Margin (TTM)73.4263.6768.9246.09Gross Margin - 5 Yr. Avg.64.0262.1268.2945.61EBITD Margin (TTM)23.8723.6624.6821.60EBITD - 5 Yr.